NYSE - Delayed Quote USD

Elanco Animal Health Incorporated (ELAN)

13.44

-0.02

(-0.15%)

At close: June 4 at 4:00:02 PM EDT

13.44

0.00

(0.00%)

After hours: June 4 at 6:24:44 PM EDT

How Elanco Plans on Winning in the Pet Wellness Boom

The animal health care company Elanco is reaffirming its second quarter and full year guidance. The company is also announcing a new CFO as the company looks to accelerate growth. Jeff Simmons, Elanco's CEO joined the C-Suite on Bloomberg's Open Interest to talk about the booming pet care market

Bloomberg 7 days ago

ELAN
-0.15%
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. VanHimbergen's appointment follows an extensive and competitive search as part of the company's commitment to long-term, sustained value creation. VanHimbergen succeeds Todd Young, who will remain with the company as an advisor through August 31, 2025, to facilitate a smooth transition.

PR Newswire 7 days ago

ELAN
-0.15%
3 Reasons to Sell ELAN and 1 Stock to Buy Instead

Elanco has been treading water for the past six months, recording a small loss of 1.3% while holding steady at $13.27.

StockStory 15 days ago

ELAN
-0.15%
Elanco to Participate in the Upcoming Investor Conferences

Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor conferences.

PR Newswire 19 days ago

ELAN
-0.15%
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.

StockStory 23 days ago

WAT

TECH

AVTR
Elanco Animal Health Incorporated Just Recorded A 117% EPS Beat: Here's What Analysts Are Forecasting Next

Elanco Animal Health Incorporated ( NYSE:ELAN ) investors will be delighted, with the company turning in some strong...

Simply Wall St. 25 days ago

ELAN
-0.15%
Elanco Animal Health Incorporated (NYSE:ELAN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Elanco Animal Health's (NYSE:ELAN) stock is up by a considerable 34% over the past month. However, we wonder if the...

Simply Wall St. 27 days ago

ELAN
-0.15%
Elanco Animal Health First Quarter 2025 Earnings: Beats Expectations

Elanco Animal Health ( NYSE:ELAN ) First Quarter 2025 Results Key Financial Results Revenue: US$1.19b (down 1.0% from...

Simply Wall St. 27 days ago

ELAN
-0.15%
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings Call Highlights: Strong Innovation Revenue and ...

Elanco Animal Health Inc (ELAN) reports robust innovation revenue and raises full-year guidance, despite facing challenges in the US retail market.

GuruFocus.com 27 days ago

ELAN
-0.15%
Why Elanco Animal Health Incorporated (ELAN) Skyrocketed On Wednesday

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Elanco Animal Health Incorporated (NYSE:ELAN) stands against other Wednesday’s best-performing stocks. The stock market rebounded on Wednesday, with all major indices ending in the green as investors cheered the Federal Reserve’s decision […]

Insider Monkey 27 days ago

ELAN
-0.15%
Update: Elanco Animal Health Shares Rise After Q1 Beat

(Updates with the latest stock movement in the headline and first paragraph.) Elanco Animal Healt

PREMIUM
MT Newswires 28 days ago

ELAN
-0.15%
Elanco (ELAN) Stock Trades Up, Here Is Why

Shares of animal health company Elanco (NYSE:ELAN) jumped 21.2% in the afternoon session after the company reported decent first quarter 2025 results which beat analysts' EPS expectations and included constant currency revenue outperformance. Organic sales were up 4%, thanks to strong demand in cattle health and good traction from new pet meds like Credelio Quattro. Even though sales were flat, operating margins improved, a sign they're managing prices and costs pretty well.

StockStory 28 days ago

ELAN
-0.15%
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 28 days ago

ELAN
-0.15%
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates

Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 19.35% and 2.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 28 days ago

ELAN
-0.15%
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations

Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $0.37 per share was 21.5% above analysts’ consensus estimates.

StockStory 28 days ago

ELAN
-0.15%
Elanco Animal Health Reports First Quarter 2025 Results

Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the first quarter of 2025, provided guidance for the second quarter of 2025, and updated guidance for the full year 2025.

PR Newswire 28 days ago

ELAN
-0.15%
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Animal health company Elanco (NYSE:ELAN) will be reporting results tomorrow before market hours. Here’s what to look for.

StockStory 29 days ago

ELAN
-0.15%

CELG-RT
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

Elanco Animal Health Incorporated (NYSE:ELAN) on Monday announced the sale of certain future tiered royalties and commercial milestones associated with Xdemvy (lotilaner ophthalmic solution) 0.25% for the human health application of lotilaner to Blackstone Life Sciences and Blackstone Credit & Insurance for $295 million in cash. The company will use the proceeds to accelerate debt reduction, positioning Elanco to achieve an expected net leverage ratio of 3.9x to 4.3x adjusted EBITDA by the end o

Benzinga 30 days ago

ELAN
-0.15%
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner, to funds affiliated with Blackstone Life Sciences and Blackstone Credit & Insurance for $295 million in cash. Monetization of this non-core asset will be used to accelerate debt reduction, positioning Elanco to achieve an expected net leverage ratio of 3.9x

PR Newswire 30 days ago

ELAN
-0.15%
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Astrana Health, Inc. (ASTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks last month

ELAN
-0.15%

Performance Overview

Return	ELAN	S&P 500 (^GSPC)
YTD	+10.98%	+1.52%
1-Year	-26.15%	+12.84%
3-Year	-44.44%	+45.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Elanco Animal Health Incorporated (ELAN)

How Elanco Plans on Winning in the Pet Wellness Boom

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

Elanco to Participate in the Upcoming Investor Conferences

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know

Elanco Animal Health Incorporated Just Recorded A 117% EPS Beat: Here's What Analysts Are Forecasting Next

Elanco Animal Health Incorporated (NYSE:ELAN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Elanco Animal Health First Quarter 2025 Earnings: Beats Expectations

Elanco Animal Health Inc (ELAN) Q1 2025 Earnings Call Highlights: Strong Innovation Revenue and ...

Why Elanco Animal Health Incorporated (ELAN) Skyrocketed On Wednesday

Update: Elanco Animal Health Shares Rise After Q1 Beat

Elanco (ELAN) Stock Trades Up, Here Is Why

Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics

Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates

Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations

Elanco Animal Health Reports First Quarter 2025 Results

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Performance Overview